HMGN5 and neoplasm: In a novel in situ strategy, another group of investigators achieved robust anti-tumor response in the 4T1 breast cancer model by pulsing dendritic cells with tumor-cell derived exosomes that were fused with the DAMP, nucleosome-binding protein 1 (HMGN1; TEX-N1ND) [95].